LRP5 and sclerosteosis: As increasing numbers of individuals are reported, it is apparent that LRP5 HBM may not be as benign as first thought, and indeed shares many features with sclerosteosis and van Buchem’s disease (Table 2)—which is not particularly surprising given they share a common pathway.